These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

815 related items for PubMed ID: 16704217

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Facile synthesis and relaxation properties of novel bispolyazamacrocyclic Gd3+ complexes: an attempt towards calcium-sensitive MRI contrast agents.
    Mishra A, Fousková P, Angelovski G, Balogh E, Mishra AK, Logothetis NK, Tóth E.
    Inorg Chem; 2008 Feb 18; 47(4):1370-81. PubMed ID: 18166011
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Target visualization by MRI using the avidin/biotin amplification route: synthesis and testing of a biotin-Gd-DOTA monoamide trimer.
    Tei L, Barge A, Geninatti Crich S, Pagliarin R, Negri V, Ramella D, Cravotto G, Aime S.
    Chemistry; 2010 Jul 19; 16(27):8080-7. PubMed ID: 20533461
    [Abstract] [Full Text] [Related]

  • 10. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
    Yang CT, Chandrasekharan P, He T, Poh Z, Raju A, Chuang KH, Robins EG.
    Biomaterials; 2014 Jan 19; 35(1):327-36. PubMed ID: 24138829
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M, Selegård L, Klasson A, Söderlind F, Abrikossova N, Skoglund C, Bengtsson T, Engström M, Käll PO, Uvdal K.
    Langmuir; 2010 Apr 20; 26(8):5753-62. PubMed ID: 20334417
    [Abstract] [Full Text] [Related]

  • 17. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
    Giesel FL, von Tengg-Kobligk H, Wilkinson ID, Siegler P, von der Lieth CW, Frank M, Lodemann KP, Essig M.
    Invest Radiol; 2006 Mar 20; 41(3):222-8. PubMed ID: 16481904
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla.
    Pintaske J, Martirosian P, Graf H, Erb G, Lodemann KP, Claussen CD, Schick F.
    Invest Radiol; 2006 Mar 20; 41(3):213-21. PubMed ID: 16481903
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and relaxivity studies of a tetranuclear gadolinium(III) complex of DO3A as a contrast-enhancing agent for MRI.
    Jebasingh B, Alexander V.
    Inorg Chem; 2005 Dec 12; 44(25):9434-43. PubMed ID: 16323930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.